[1]王晓雨,向阳*.妊娠合并滋养细胞疾病的诊治进展[J].中国计划生育和妇产科,2019,(2):6-9.
点击复制

妊娠合并滋养细胞疾病的诊治进展
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年2期
页码:
6-9
栏目:
综述
出版日期:
2019-02-25

文章信息/Info

作者:
王晓雨向阳*
中国医学科学院北京协和医学院北京协和医院妇产科
关键词:
妊娠滋养细胞疾病诊治
分类号:
R 737.3

参考文献/References:

[1]SEBIRE N J, FOSKETT M, PARADINAS F J, et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin [J]. Lancet, 2002, 359(9324): 2165-2166. [2]WEE L, JAUNIAUX E. Prenatal diagnosis and management of twin pregnancies complicated by a co-existing molar pregnancy[J]. Prenatal Diagnosis, 2005, 25(9): 772-776. [3]LIN L H, MAEST I, BRAGA A, et al. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review[J]. Gynecologic Oncology, 2017, 145(1): 88-95. [4]MATSUI H, SEKIYA S, HANDO T, et al. Hydatidiform mole coexistent with a twin live fetus: a National collaborative study in Japan [J]. Human Reproduction (Oxford, England), 2000, 15(3): 608-611. [5]MASSARDIER J, GOLFIER F, JOURNET D, et al. Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009, 143(2): 84-87. [6]NIEMANN Isa, SUNDE L, PETERSEN L K. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus[J]. American Journal of Obstetrics and Gynecology, 2007, 197(1): 45.e1-45.e5. [7]LEE S W, KIM M Y, CHUNG J H, et al. Clinical findings of multiple pregnancy with a complete hydatidiform mole and coexisting fetus[J]. Journal of Ultrasound in Medicine, 2010, 29(2): 271-280. [8]Niemann I, Fisher R, Sebire N, et al. Update on UK outcomes for women with twin pregnancies comparimising a complete hydatidiform mole (CHM) and a normal co-twin[J].World Congr Gestation Trophobl 2013:57. [9]KIHARA M, USUI H, TANAKA H, et al. Complicating preeclampsia as a predictor of poor survival of the fetus in complete hydatidiform mole coexistent with twin fetus[J]. The Journal of Reproductive Medicine, 2012, 57(7/8): 325-328. [10]SCHOOLMEESTER J K, ERICKSON L A. Gestational trophoblastic disease[J]. Mayo Clinic Proceedings, 2017, 92(11): 1739-1740. [11]ALBAYRAK M, OZER A, DEMIR O F, et al. Complete mole coexistent with a twin fetus[J]. Archives of Gynecology and Obstetrics, 2010, 281(1): 119-122. [12]COPELAND J W, STANEK J. Dizygotic twin pregnancy with a normal fetus and a nodular embryo associated with a partial hydatidiform mole[J]. Pediatric and Developmental Pathology, 2010, 13(6): 476-480. [13]CHU Wenjiang, CHAPMAN J, PERSONS D L, et al. Twin pregnancy with partial hydatidiform mole and coexistent fetus [J]. Archives of Pathology & Laboratory Medicine, 2004, 128(11): 1305-1306. [14]STELLER M A, GENEST D R, BERNSTEIN M R, et al. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses [J]. The Journal of Reproductive Medicine, 1994, 39(3): 147-154. [15]KASHIMURA Y, TANAKA M, HARADA N, et al. Twin pregnancy consisting of 46, XY heterozygous complete mole coexisting with a live fetus[J]. Placenta, 2001, 22(4): 323-327. [16]OKUMURA M, FUSHIDA K, FRANCISCO R P, et al. Massive necrosis of a complete hydatidiform mole in a twin pregnancy with a surviving coexistent fetus [J]. Journal of Ultrasound in Medicine, 2014, 33(1): 177-179. [17]FISHMAN D A, PADILLA L A, KEH P, et al. Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus [J]. Obstetrics and Gynecology, 1998, 91(4): 546-550. [18]HIMOTO Y, KIDO A, MINAMIGUCHI S, et al. Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging [J]. The Journal of Obstetrics and Gynaecology Research, 2014, 40(7): 1894-1900. [19]WU Te-chang, SHEN S H, CHANG Sheng-ping, et al. Magnetic resonance experience of a twin pregnancy with a normal fetus and hydatidiform mole: a case report[J]. Journal of Computer Assisted Tomography, 2005, 29(3): 415-417. [20]ISHII J, IITSUKA Y, TAKANO H, et al. Genetic differentiation of complete hydatidiformmoles coexisting with normal fetuses by short tandem repeat-derived deoxyribonucleic acid polymorphism analysis[J]. American Journal of Obstetrics and Gynecology, 1998, 179(3 Pt 1): 628-634. [21]SUKSAI M, SUWANRATH C, KOR-ANANTAKUL O, et al. Complete hydatidiform mole with co-existing fetus: Predictors of live birth [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017, 212: 1-8. [22]JIAO L, GHORANI E, SEBIRE N J, et al. Intraplacental choriocarcinoma: Systematic review and management guidance[J]. Gynecologic Oncology, 2016, 141(3): 624-631. [23]SEBIRE N J, LINDSAY I, FISHER R A, et al. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma[J]. Fetal and Pediatric Pathology, 2005, 24(1): 21-29. [24]FOX H, LAURINI R N. Intraplacental choriocarcinoma: a report of two cases[J]. Journal of Clinical Pathology, 1988, 41(10): 1085-1088. [25]GANAPATHI K A, PACZOS T, GEORGE M D, et al. Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature[J]. International Journal of Gynecological Pathology, 2010, 29(5): 476-478. [26]CHUNG C, KAO M S, GERSELL D. Incidental placental choriocarcinoma in a term pregnancy: a case report [J]. Journal of Medical Case Reports, 2008, 2: 330. [27]KANEHIRA K, STAROSTIK P, KASZNICA J, et al. Primary intraplacental gestational choriocarcinoma: histologic and genetic analyses [J]. International Journal of Gynecological Pathology, 2013, 32(1): 71-75. [28]YAMAMOTO E, NIIMI K, SHINJO K, et al. Identification of causative pregnancy of gestational trophoblastic neoplasia diagnosed during pregnancy by short tandem repeat analysis [J]. Gynecologic Oncology Case Reports, 2014, 9: 3-6. [29]JACQUES S M, QURESHI F. Intraplacentalchoriocarcinoma without associated maternal or fetal metastases[J]. International Journal of Gynecological Pathology, 2011, 30(4): 364-365. [30]AVRIL M F, MATHIEU A, KALIFA C, et al. Infantile choriocarcinoma with cutaneous tumors. An additional case and review of the literature [J]. Journal of the American Academy of Dermatology, 1986, 14(5 Pt 2): 918-927. [31]LANDAU D, MAOR E, MAYMON E, et al. Intraplacental choriocarcinoma metastasizing to the maternal lung [J]. European Journal of Gynaecological Oncology, 2006, 27(1): 29-32. [32]SHE Qin, CHENG Zhi, EL-CHAAR D, et al. Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: Case report, chemotherapy management, and literature review [J]. Medicine, 2018, 97(14): e9977. [33]KOIKE Y, WAKAMATSU H, KUROKI Y, et al. Fetomaternal hemorrhage caused by intraplacentalchoriocarcinoma: a case report and review of literature in Japan[J]. American Journal of Perinatology, 2006, 23(1): 49-52. [34]LIU Jianping, GUO Lina. Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature [J]. Gynecologic Oncology, 2006, 103(3): 1147-1151.

相似文献/References:

[1]阚滨,肖美霞.妊娠合并血小板减少症65例临床分析[J].中国计划生育和妇产科,2009,(05):0.
 KAN Bin,XIAO Mei-xia The department of gynaecology and obstetrics,Shengli hospital of Rugao city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(2):0.
[2]廖治,杨业洲.多发性硬化和妊娠[J].中国计划生育和妇产科,2009,(05):0.
[3]周萍,李秀美,江彩虹,等.妊娠合并卵巢肿瘤98例临床分析[J].中国计划生育和妇产科,2010,(02):0.
[4]莫丽芳.剖宫产手术中行子宫肌瘤剔除术体会[J].中国计划生育和妇产科,2010,(04):0.
 MO Li-fang Shilong Peoples hospital of Dongguan city,Dongguan Guangdong,China.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[5]何博.妊娠合并先天性心脏病的诊治研究进展[J].中国计划生育和妇产科,2010,(04):0.
[6]韩雪玲.妊娠期合并尖锐湿疣200例治疗方法比较[J].中国计划生育和妇产科,2011,(04):0.
 HAN Xue-ling.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[7]张帆.孕妇哮喘及其安全监护[J].中国计划生育和妇产科,2011,(05):0.
 ZHANG Fan Chinese Medical Doctor Association in Beijing,Beijing 000,P.R.China.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[8]朱林,车兰芬.不同剂量米非司酮用于妊娠10~14周流产的临床观察[J].中国计划生育和妇产科,2012,(04):0.
 ZHU Lin,CHE Lan-fen.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[9]韦冰,车小群,许丽华,等.血清CA125在评估卵巢子宫内膜异位囊肿的分期及术后妊娠情况中的价值[J].中国计划生育和妇产科,2012,(06):0.
 WEI Bing*,CHE Xiao-qun,XU Li-hua Center of reproductive medicine,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[10]孙国娟.不同剂量米非司酮用于妊娠8~10周流产的临床观察[J].中国计划生育和妇产科,2013,(05):0.
 SUN Guo-juan,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.

更新日期/Last Update: 2019-02-25